Lumos Diagnostics Narrows Losses, Revenue Up
Company Announcements

Lumos Diagnostics Narrows Losses, Revenue Up

Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.

Lumos Diagnostics Holdings Limited reports a slight revenue increase of 5.7% to $11,131 thousand for the fiscal year ended June 30, 2024, while reducing its annual loss by 4.2% to $8,592 thousand compared to the previous year. The company’s net tangible assets per security went further negative, now at (0.37) US cents. Despite the modest financial improvements, Lumos did not issue any dividends this financial year and an unmodified audit opinion was given, noting a material uncertainty related to the company’s ongoing viability.

For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App